Association between polypharmacy and the adherence to pharmacological treatment in patients with diabetes

Authors

  • Kiarelle Lourenço Penaforte
  • Samila Torquato Araújo
  • Virginia Oliveira Fernandes
  • Islene Victor Barbosa
  • Virna Ribeiro Feitosa Cestari
  • Renan Magalhães Montenegro Júnior

DOI:

https://doi.org/10.15253/2175-6783.2017000500010

Keywords:

Diabetes Mellitus, Type 2, Therapeutics, Polypharmacy, Medication Adherence, Nursing.

Abstract

Objective: to evaluate the occurrence of polypharmacy and its association with the adherence to the pharmacological treatment in patients with diabetes mellitus type 2. Methods: cross-sectional study conducted with 235 patients with diabetes mellitus type 2 through interview about the demographic and clinical data, drug therapy prescribed and adherence to treatment. To analyze the data, we used Student t-tests and Chi-square, with significance level p<0.05. Results: polypharmacy was evidenced in 88.4% of cases with a predominance of moderate level. An average of 7.5 pills per person among the 19 types of prescribed drugs were used. Adherence to prescribed therapy was reported by 88.2% of patients evaluated and there was no association with polypharmacy (p=0.266). Conclusion: it was verified that polypharmacy is a condition of high prevalence and is not associated with worse adherence to therapy.

Downloads

Published

2017-11-21

How to Cite

Penaforte, K. L., Araújo, S. T., Fernandes, V. O., Barbosa, I. V., Cestari, V. R. F., & Montenegro Júnior, R. M. (2017). Association between polypharmacy and the adherence to pharmacological treatment in patients with diabetes. Rev Rene, 18(5), 631–638. https://doi.org/10.15253/2175-6783.2017000500010

Issue

Section

Letters to the editor

Most read articles by the same author(s)